Bioprocessing White Papers

1. Three Key Actions To Minimize Dead Volumes 10/10/2025

   Minimizing liquid dead volume helps labs conserve costly reagents and scarce samples while boosting assay throughput. Learn how advanced liquid level detection technologies are driving efficiency.

2. Calculating The ROI Of EAM/CMMS For Pharma Manufacturers And CDMOs 10/6/2025

   Learn how modern EAM and CMMS systems help pharma manufacturers reduce risk, improve compliance, and cut costs, as well as nine signs it’s time to move beyond outdated asset management practices.

3. Streamline Your AAV Process With A Production Platform 10/6/2025

   AAVs are reshaping gene therapy, but scaling production introduces complexity. Learn how upstream process optimization can improve yield, consistency, and speed to meet growing demands.

4. Achieve Higher Targeted Concentrations 9/30/2025

   Single-pass TFF streamlines downstream processing by reducing footprint, shear exposure, and hold-up volumes. Learn how this approach is advancing efficiency across therapeutic and vaccine production.

5. Improving Methodologies For iPSC Manufacturing And Differentiation 9/30/2025

   Learn how next-generation workflows are being developed to streamline iPSC manufacturing, enhance differentiation strategies, and overcome the hurdles of scalability and consistency.

6. Innovation And Evolution Of Affinity Chromatography Resins For Monoclonal Antibody Purification 9/30/2025

   Discover how innovations in ligand design and resin manufacturing have improved monoclonal antibody purification by enhancing selectivity, stability, and process economics.

7. Molecular Approaches To Streamline Cell Therapy Product Analytical Testing 9/26/2025

   Learn how rapid molecular methods of cell therapy testing like qPCR for mycoplasma, sterility, and lentiviral quantification are key to accelerating product release and timely treatment delivery.

8. Beyond Traditional Monoclonal Antibodies 9/24/2025

   New antibody formats present new purification challenges due to novel impurity profiles. New methods and media are required to ensure safe, effective, and scalable manufacturing of these biologics.

9. Optimizing Charge And N-glycan Profiles For CHO-Derived Fusion Proteins 9/24/2025

   Discover how structured design-of-experiment approaches can optimize charge variants and glycosylation to enhance biologics quality and therapeutic performance.

10. A Comparative Analysis Between Liquid Nitrogen And Mechanical Freezers 9/23/2025

    Explore the differences between liquid nitrogen and mechanical cryogenic freezers, and learn how each method supports scientific, medical, and industrial storage needs.